Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 10:57 PM
NCT ID:
NCT05507567
Recruitment Details:
Following screening (Day -93 to Day -5), this study was conducted with an inpatient phase (Day -4 to Day 8) and an outpatient follow-up on Day 28 (plus or minus 3 days). During the inpatient quarantine phase, participants received Neumifil or placebo according to the randomisation on Day -3, Day -2 and Day -1, and then received Influenza Challenge Virus on Day 0. The study was conducted at one site in the UK between 12 August 2022 and 03 May 2023.
Study:
NCT05507567
Study Brief:
Results Section:
NCT05507567